Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
No health without mental health
2007 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
A Tetrameric Porin Limits the Cell Wall Permeability ofMycobacterium smegmatis
2002
Trends in tuberculosis incidence and their determinants in 134 countries
2009
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
2016 Standout
Combinatorial drug therapy for cancer in the post-genomic era
2012
DnaE2 Polymerase Contributes to In Vivo Survival and the Emergence of Drug Resistance in Mycobacterium tuberculosis
2003
Syndemics and the biosocial conception of health
2017 Standout
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
2005
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
2007
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
WHO's new Stop TB Strategy
2006
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Mycolic Acid Modification by the mmaA4 Gene of M. tuberculosis Modulates IL-12 Production
2008
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
2005
International Standards for Tuberculosis Care
2006
Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study
2005
Cost effectiveness analysis of strategies for tuberculosis control in developing countries
2005
Tuberculosis Drug Resistance: A Global Threat
2003
Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
2005
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
2007
Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations
2007
Diagnostics for the developing world
2004 Standout
Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system
2010
Programmes and principles in treatment of multidrug-resistant tuberculosis
2004
Global Trends in Resistance to Antituberculosis Drugs
2001
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
The Infectiousness of Tuberculosis Patients Coinfected with HIV
2008
Global Incidence of Multidrug‐Resistant Tuberculosis
2006
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
2007
Human papillomavirus and cervical cancer
2007 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
The Mycobacterium tuberculosis Virulence Factor Trehalose Dimycolate Imparts Desiccation Resistance to Model Mycobacterial Membranes
2008 StandoutNobel
Measuring tuberculosis burden, trends, and the impact of control programmes
2008
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Sensitivity optimisation of tuberculosis bioaerosol sampling
2020 StandoutNobel
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
2010
A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
2011
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical Assessment
2008
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment
2006
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: Update 2012
2012
The double burden of communicable and non-communicable diseases in developing countries
2005 Standout
Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
2014 Standout
The global situation of MDR-TB
2003
Tuberculosis
2003
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Down syndrome
2020 Standout
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
2009 StandoutNobel
Sulfate Metabolism in Mycobacteria
2006 StandoutNobel
How antibiotics kill bacteria: from targets to networks
2010 Standout
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
2006
5′‐Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
2006 StandoutNobel
The Growing Burden of Tuberculosis
2003 Standout
Multidrug-resistant tuberculosis at an HIV testing center in Haiti
2006
Can Treatment Adherence Be Improved by Using Rubin's Four Tendencies Framework to Understand a Patient's Response to Expectations
2017 Standout
Active community surveillance of the impact of different tuberculosis control measures, Tiruvallur, South India, 1968–2001
2006
Multidrug-Resistant Tuberculosis
2006
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.
2002
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
2002 Science
Criteria for the control of drug-resistant tuberculosis
2000
INCIDENCE OF POLARIZING FOREIGN BODIES IN LUNG BIOPSIES OF PATIENTS WITH PULMONARY SARCOIDOSIS
2006
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
2006
Directly observed therapy for treating tuberculosis
2015
The Immune Response in Tuberculosis
2013 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Economic benefit of Tuberculosis control
2007
Point-of-Care Diagnostics for Global Health
2008 Standout
Genetic requirements for mycobacterial survival during infection
2003 Standout
Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings
2004
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
2007
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador.
2010
Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis
2002 Standout
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant
2007 StandoutNobel
Works of Pedro Suarez being referenced
The Dynamics of Tuberculosis in Response to 10 Years of Intensive Control Effort in Peru
2001
Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis
2000
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru
2002
Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study
2013
Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study
2007
Increasing transparency in partnerships for health – introducing the Green Light Committee
2002
Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents
2013
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
2001
Multidrug-resistantMycobacterium tuberculosisin HIV-Infected Persons, Peru
2003